首页> 外文期刊>FEBS Open Bio >MiR‐29a‐3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1
【24h】

MiR‐29a‐3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1

机译:MiR‐29a‐3p通过靶向prominin 1抑制喉癌细胞增殖

获取原文
获取外文期刊封面目录资料

摘要

MicroRNAs (miRNAs) are known to play a regulatory role in various cancers including laryngocarcinoma. MiR‐29a‐3p is a potential tumor‐suppressive miRNA, but its function in laryngocarcinoma is unknown. The purpose of this study was to investigate the roles of miR‐29a‐3p in laryngocarcinoma. Prominin1 (PROM1) was predicted as a target gene of miR‐29a‐3p and this was verified using a luciferase reporter assay. Transfection of miR‐29a‐3p into two laryngocarcinoma cell lines indicated that miR‐29a‐3p could decrease cell proliferation and enhance the chemotherapy response by targeting PROM1. PROM1 expression was up‐regulated in the laryngocarcinoma cells when miR‐29a‐3p was down‐regulated. We found miR‐29a‐3p expression levels were lower in laryngocarcinoma tissues than in control tissues. We also found that miR‐29a‐3p expression was negatively correlated with PROM1 expression in laryngocarcinoma tissues. The study demonstrates that miR‐29a‐3p suppresses cell proliferation in laryngocarcinoma by targeting PROM1.
机译:已知MicroRNA(miRNA)在包括喉癌在内的各种癌症中起调节作用。 MiR‐29a‐3p是一种潜在的肿瘤抑制性miRNA,但其在喉癌中的功能尚不清楚。这项研究的目的是调查miR‐29a‐3p在喉癌中的作用。 Prominin1(PROM1)被预测为miR‐29a‐3p的靶基因,并已通过荧光素酶报告基因检测法进行了验证。将miR‐29a‐3p转染到两个喉癌细胞系中,表明miR‐29a‐3p可通过靶向PROM1来减少细胞增殖并增强化学疗法的反应。当miR-29a-3p下调时,喉癌细胞中的PROM1表达上调。我们发现喉癌组织中的miR‐29a‐3p表达水平低于对照组织。我们还发现,miR-29a-3p表达与喉癌组织中的PROM1表达呈负相关。该研究表明,miR-29a-3p通过靶向PROM1抑制喉癌细胞增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号